Both genetic knockdown and small molecule inhibition of PLK4 decreased cell viability and proliferation in cSCC and BCC cells and reduced tumor growth in xenograft models while inducing apoptosis and cell cycle arrest and modulating key cancer-related genes in vitro [19]. The gene discussed is PLK4; the disease is cancer.